The illustration that accompanied this news release on a study involving rodents.
This news release from Stony Brook University in New York describes a preliminary research finding that suggests sleeping on your side rather than in a prone (lying flat, face downward) or supine (lying face upward) position aids the elimination of metabolic waste products that build up in the brain while asleep. It’s definitely an interesting finding that supports research published in 2013 from the University of Rochester. The problem with both of these studies is that, to date, none of these findings have been replicated in humans. In reality, only about one-third of findings in animals translate to successful interventions in people. The release hints at this issue by stating that the researchers’ hunch on sleeping posture and waste-clearing efficiency is just that — speculation — and that human studies are required to know for certain. But the release should have alerted readers that the study involved anesthetized rodents, and not sleeping humans, earlier in the text.
Science has made it increasingly clear that sleep plays important roles in overall health — not just our mood and alertness. And this release suggests that certain sleep positions may help “flush out” potentially harmful proteins like tao and amyloid which are found in greater quantities in the brains of people with Alzheimer’s. That intriguing finding could, one day, prove relevant to efforts to prevent this dreaded disease in humans. But it’s far too soon for anyone to consider adjusting their own sleep practices based on these findings.
Cost is not an applicable criteria since there’s no cost associated with sleeping (unless one goes to a sleep clinic).
We identified two important problems with the way benefits are described:
The harm of changing one’s sleeping pattern is not addressed. While there are people with certain health conditions that can’t sleep on their side, it doesn’t seem like an applicable criteria for rating this release.
The news release adequately explains how they came to observe the glymphatic pathway in rodents using dynamic contrast magnetic resonance imaging (MRI). However, the notification that the study involved rodents comes a bit far down in the release for our liking — well after the release has suggested the findings could have important implications for Alzheimer’s disease prevention in humans. In addition, the release doesn’t describe any of the study parameters such as the size of the rodent sample, the key measurements, or study length.
There is one silver lining, in terms of quality of evidence, and it’s this line at the end of the release: “Dr.Benveniste cautioned that while the research team speculates that the human glymphatic pathway will clear brain waste most efficiency when sleeping in the lateral position as compared to other positions, testing with MRI or other imaging methods in humans are a necessary first step.” Although that’s a welcome caveat, we think it comes too late in a release describing such a very preliminary study.
We saw no evidence of disease mongering. The release is careful to talk about efficiency in clearing brain waste and doesn’t suggest that a non-prone position could be harmful.
The release does not tell us who funded the study. According to the study, the work was supported by “FBRI” (not clear what that stands for), the National Institutes of Health, and the Department of Anesthesiology at Stony Brook Medicine.
The release compared the potential benefit of sleeping on one’s side and on the stomach or back. But there are many other potentially modifiable risk factors for Alzheimer’s and other neurodegenerative diseases that weren’t mentioned. Things like exercise, a healthy diet. maintaining social connections, etc have been more thoroughly studied than sleep positions.
Because everyone sleeps this criteria doesn’t apply for this particular release.
The release states that SBU researchers discovered that lateral sleeping is the best method for removing waste from the brain. The researchers are apparently building on the research of University of Rochester scientists who discovered and named the glymphatic system, a network that drains waste from the brain, in 2013.
The Not Satisfactory rating here applies to the accompanying artwork as much as it does the text — the illustration depicts a human, but we think it would have been more appropriate to show a sleeping rodent. The release also makes statements that clearly refer to humans or refer to rodents and humans as interchangeable, and we don’t think the disclosure near the bottom that “testing with MRI or other imaging methods in humans are a necessary first step” is enough to counterbalance this.
Systematic, Criteria-Driven
Monday at #ADA2021, an infectious disease epidemiologist, a journalist, and a researcher shared perspectives on communication of risk in the era of COVID-19: http://ow.ly/ROfR30rMeE7 @AstleyCM @garyschwitzer @berthahidalgo @ADA_DiabetesPro
Shoutouts to @susan_bewley @drkevinknopf @MichaelBaum11 in this call for more than fawning coverage from press releases for these kinds of stories.
Also, linked history inside goes back 5 years just on Grail apparently trying to become Holy Grail. https://twitter.com/garyschwitzer/status/1408849696416841731
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like